A patient in the emergency department with an acute anterior myocardial infarction is experiencing episodes of ventricular tachycardia despite treatment. Which nursing intervention is the highest priority to prevent further deterioration of the patient's condition?

B) Prepare for synchronized cardioversion to restore a stable heart rhythm.

A) Increase the oxygen flow rate to improve saturation levels.

B) Prepare for synchronized cardioversion to restore a stable heart rhythm.

C) Administer additional doses of anticoagulants to prevent thrombus formation.

D) Encourage the patient to perform deep breathing exercises to reduce anxiety.

A patient with an acute anterior myocardial infarction is experiencing ventricular tachycardia and fluctuating blood pressure despite treatment. Which nursing intervention is the most critical to stabilize the patient's condition?

C) Prepare for synchronized cardioversion

A) Administer additional bolus of nitroglycerin

C) Prepare for synchronized cardioversion

D) Administer intravenous fluids rapidly

A patient with an anterior myocardial infarction is experiencing worsening hypoxemia and has been diagnosed with acute heart failure. The healthcare team has initiated diuretic therapy with intravenous furosemide. Which assessment finding would indicate that the diuretic therapy is having the desired effect?

A) Decreased jugular venous distention

D) Worsening crackles in the lungs

A patient with an anterior myocardial infarction develops acute heart failure, as evidenced by decreased ejection fraction and pulmonary edema. The healthcare team initiates intravenous furosemide to manage the fluid overload. Which assessment finding indicates that the diuretic therapy is effective?

D) Oxygen saturation improves to 94% on room air

A) Blood pressure stabilizes at 90/60 mmHg

B) Jugular venous distention is no longer visible

C) Heart rate decreases from 110 to 95 beats per minute

D) Oxygen saturation improves to 94% on room air

A patient receiving intravenous furosemide therapy for heart failure exhibits signs of hypokalemia, including muscle weakness and arrhythmias. The healthcare team initiates potassium replacement therapy. Which nursing intervention is most critical to ensure patient safety during potassium administration?

C) Assess the patient's cardiac rhythm continuously.

A) Monitor the patient's blood pressure every hour.

B) Administer potassium chloride via IV push to rapidly correct hypokalemia.

C) Assess the patient's cardiac rhythm continuously.

D) Encourage the patient to increase oral fluid intake to promote potassium absorption.

A patient with heart failure is receiving potassium replacement therapy and shows improvement in cardiac rhythm. However, the patient later exhibits increased respiratory rate, mild peripheral edema, and reduced ejection fraction. Which nursing intervention is most appropriate to address the patient's current condition?

C) Monitor the patient's renal function and adjust ACE inhibitor therapy as needed.

A) Increase the dosage of diuretics to reduce fluid overload.

B) Encourage the patient to perform deep breathing exercises to improve oxygenation.

C) Monitor the patient's renal function and adjust ACE inhibitor therapy as needed.

D) Restrict the patient's fluid intake to prevent further pulmonary congestion.

A nurse is reviewing the plan of care for a patient with heart failure who recently showed signs of pulmonary congestion and reduced ejection fraction. The healthcare team has initiated an ACE inhibitor and is considering the addition of a beta-blocker. Which nursing intervention is most important to implement at this time?

A) Monitor the patient's blood pressure and heart rate closely before and after administering new medications

B) Educate the patient on the importance of daily weight monitoring to assess fluid status

C) Encourage the patient to increase fluid intake to assist with renal function

D) Advise the patient to limit physical activity to prevent fatigue

A patient with heart failure is experiencing elevated respiratory rate, a non-productive cough, and an increase in serum creatinine and potassium levels after starting ACE inhibitor therapy. What is the most appropriate nursing intervention to prevent further complications?

B) Educate the patient on a low-potassium diet and monitor serum levels closely.

A) Encourage increased fluid intake to flush out excess potassium.

B) Educate the patient on a low-potassium diet and monitor serum levels closely.

C) Suggest the patient discontinue the ACE inhibitor until renal function improves.

D) Increase the patient's activity level to improve respiratory status.

A patient on ACE inhibitor therapy presents with a slight increase in serum creatinine levels and hyperkalemia. The healthcare team is considering introducing a low-dose beta-blocker to support cardiac function. Which nursing intervention is most appropriate in this situation to address the patient's current clinical status?

B) Monitor the patient's serum electrolyte levels closely and educate on a low-potassium diet.

A) Encourage the patient to increase fluid intake to improve renal function.

B) Monitor the patient's serum electrolyte levels closely and educate on a low-potassium diet.

C) Advise the patient to reduce physical activity to minimize respiratory distress.

D) Discontinue the ACE inhibitor immediately to prevent further renal impairment.

Heart attack - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis leads to the formation of plaques in coronary arteries. These plaques narrow the arteries, reducing blood flow and oxygen supply to the heart muscle, which can culminate in myocardial ischemia.

• Secondary mechanism: Plaque rupture triggers the formation of a blood clot (thrombus), which can completely occlude the coronary artery. This blockage halts blood flow, causing the affected heart tissue to become necrotic, leading to a myocardial infarction.

• Key complication: Reduced blood supply and tissue death can lead to impaired heart function, potentially resulting in heart failure or arrhythmias, which are life-threatening if not promptly addressed.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Smoker for 30 years

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, sweating, lightheadedness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

As the patient is assessed in the emergency department, initial findings highlight a progression of his condition. The electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads, confirming an acute anterior myocardial infarction. His troponin levels are significantly elevated, indicating ongoing myocardial injury. Additionally, the patient's physical examination reveals cool, clammy skin, and jugular venous distention, suggesting an increase in central venous pressure and possible early signs of heart failure. Despite the administration of supplemental oxygen, his oxygen saturation remains at 92%, indicating a persistent oxygenation issue.

In response to his deteriorating status, the medical team initiates treatment with nitroglycerin to relieve chest pain and improve coronary blood flow, alongside anticoagulants to prevent further thrombus formation. However, the patient begins to experience episodes of ventricular tachycardia, a serious arrhythmia that could exacerbate his condition. This arrhythmia is likely due to myocardial irritability from ischemic damage, necessitating immediate intervention to stabilize his heart rhythm and prevent progression to ventricular fibrillation.

The emergence of ventricular tachycardia complicates the clinical picture and demands prompt action. The healthcare team administers intravenous amiodarone, an antiarrhythmic agent, to control the arrhythmia and carefully monitors the patient's hemodynamic status. Despite these efforts, his blood pressure remains labile, fluctuating between hypertensive and hypotensive episodes, which requires careful titration of medications and fluid management. This situation underscores the need for continuous cardiac monitoring and reassessment to prevent further complications such as cardiogenic shock, highlighting the critical importance of timely and effective intervention in managing acute myocardial infarction with complications.

Section 2

As the medical team continues to closely monitor the patient, a new complication arises. The patient's oxygen saturation drops further to 88%, indicating worsening hypoxemia despite supplemental oxygen therapy. Auscultation of the lungs reveals bilateral crackles, particularly in the lower lobes, suggesting pulmonary congestion. This clinical presentation, combined with the earlier signs of jugular venous distention and cool, clammy skin, raises concern for the development of acute heart failure due to the anterior myocardial infarction.

In response to these changes, the healthcare team orders a chest X-ray and an echocardiogram to evaluate the extent of pulmonary edema and assess left ventricular function. The chest X-ray confirms bilateral pulmonary edema, and the echocardiogram reveals reduced ejection fraction, indicating impaired cardiac output. Laboratory tests show an increase in B-type natriuretic peptide (BNP) levels, corroborating the diagnosis of heart failure. These findings necessitate the initiation of diuretic therapy with intravenous furosemide to alleviate fluid overload and improve respiratory function.

The patient's condition prompts a reassessment of the treatment plan. The team adjusts the nitroglycerin dosage to optimize coronary perfusion without exacerbating hypotensive episodes. Continuous monitoring of vital signs, fluid balance, and electrolyte levels is essential to prevent further deterioration. These measures, coupled with the ongoing administration of antiarrhythmic therapy, aim to stabilize the patient and prevent progression to cardiogenic shock. The healthcare team remains vigilant, understanding the complexity of managing an acute myocardial infarction complicated by heart failure and arrhythmia, and prepares for potential further interventions.

Section 3

As the patient undergoes treatment with intravenous furosemide, the healthcare team keenly observes for signs of diuretic response and overall improvement in respiratory function. Within a few hours, the patient begins to experience increased urine output, which is a positive indication of fluid removal. However, as the diuretic therapy progresses, the patient starts complaining of muscle weakness and abdominal cramping. The nurse promptly assesses the patient and discovers a heart rate of 112 beats per minute, blood pressure of 98/60 mmHg, and newly developed premature ventricular contractions on the cardiac monitor.

Concerned about the electrolyte balance, the team immediately orders a basic metabolic panel. The results show hypokalemia with a serum potassium level of 3.1 mmol/L, which explains the muscle weakness and arrhythmias. Recognizing the need to address this complication, the healthcare team initiates potassium replacement therapy while continuing to monitor the patient's cardiac rhythm closely. The plan includes administering potassium chloride intravenously, carefully titrated to avoid rapid shifts that could precipitate further cardiac instability.

The onset of hypokalemia adds an additional layer of complexity to the patient's management, highlighting the delicate balance required in treating heart failure and its complications. The healthcare team emphasizes the importance of regular electrolyte monitoring and adjusts the diuretic regimen to prevent further electrolyte imbalances. As the patient stabilizes with corrected potassium levels, the focus shifts to optimizing cardiac function and preventing recurrent arrhythmias, while maintaining vigilant observation for any new signs of deterioration. This approach ensures comprehensive care tailored to the intricacies of the patient's evolving clinical condition.

Section 4

As the potassium replacement therapy continues, the healthcare team notices a gradual improvement in the patient's cardiac rhythm and muscle strength. The patient's heart rate stabilizes at 88 beats per minute, and the premature ventricular contractions begin to diminish in frequency. Blood pressure readings also show a slight improvement, now at 104/68 mmHg. However, the team remains vigilant, aware that heart failure management requires ongoing assessment and adaptation to prevent further complications.

During the next shift, the nurse conducts a routine assessment and observes a slight increase in the patient's respiratory rate, now at 24 breaths per minute, compared to the previous readings. The patient mentions feeling slightly breathless and exhibits mild peripheral edema, particularly in the lower extremities. Given these findings, the healthcare team decides to re-evaluate the patient's fluid status and cardiac function by ordering a follow-up chest X-ray and echocardiogram. The chest X-ray reveals mild pulmonary congestion, and the echocardiogram indicates a reduced ejection fraction compared to initial measurements. These results suggest that despite the initial diuretic response, the patient’s heart failure is not yet optimally controlled.

Recognizing the need for a more comprehensive approach, the healthcare team decides to adjust the treatment regimen. They initiate an ACE inhibitor to improve cardiac function and reduce preload and afterload while continuing to carefully monitor the patient's renal function and electrolyte levels. The team also considers the potential addition of a beta-blocker, contingent on further stabilization of cardiac output and blood pressure. This strategic adjustment aims to enhance cardiac efficiency and prevent further fluid overload, focusing on both immediate and long-term goals for the patient's recovery. The healthcare team remains committed to closely monitoring the patient’s response to these interventions, ready to make further adjustments as necessary to tailor the management plan to the patient's unique clinical needs.

Section 5

As the healthcare team continues to monitor the patient’s response to the adjusted treatment regimen, they observe notable changes in the patient's clinical status. Over the next 48 hours, the patient reports a slight alleviation in breathlessness, and the peripheral edema shows mild improvement. However, during a routine assessment, the nurse notes that the patient's respiratory rate remains elevated at 22 breaths per minute, and there is a persistent, though non-productive, cough.

Laboratory results reveal a slight increase in serum creatinine levels, now at 1.6 mg/dL from the previous 1.2 mg/dL, raising concerns about renal function in the context of ACE inhibitor therapy. Additionally, the patient's potassium level has risen to 5.2 mmol/L, warranting careful consideration to avoid hyperkalemia. Despite these concerns, the patient's blood pressure continues to stabilize, with readings averaging around 110/70 mmHg, and the heart rate remains steady at 84 beats per minute.

The healthcare team deliberates on the next steps, considering the potential benefits of introducing a low-dose beta-blocker to further support cardiac function while continuing to monitor renal function closely. They also emphasize the importance of dietary modifications to manage electrolyte levels and prevent further complications. The interdisciplinary team, including a dietitian and pharmacist, collaborates to develop a comprehensive care plan that addresses these evolving needs. The team remains vigilant, prepared to make dynamic adjustments to the treatment plan, ensuring it aligns with the patient's changing clinical picture and optimizes long-term outcomes.